Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old

Last updated: September 5, 2024
Sponsor: Centre Hospitalier Universitaire de Besancon
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Personalized psychotherapy

Standard of care

Clinical Study ID

NCT05206708
2020/484
  • Ages < 3
  • All Genders

Study Summary

This study aims to assess the efficacy at 4 months of a personalized strategy comparatively to a standard Psychodynamic Integrative Therapy, on childrens' symptom improvment

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Families who are requesting a consultation for functional or behavioural problems oftheir child

  • Children under the age of 3

Exclusion

Exclusion Criteria:

  • Parents suffering from a severe untreated psychiatric disorder

  • Difficulties in speaking French

  • Children with Autistic spectrum disorder

  • Families already in care

Study Design

Total Participants: 234
Treatment Group(s): 2
Primary Treatment: Personalized psychotherapy
Phase:
Study Start date:
February 28, 2022
Estimated Completion Date:
August 31, 2026

Study Description

3 evaluations are performed: before treatment, at the end of the treatment and one year after the treatment.

evaluations include assessment of: children's symptom parent-infant interaction quality parental competencies parental perception of the child by his/her parent parent-therapist alliance hair cortisol concentration

Connect with a study center

  • CHU de Besançon

    Besançon,
    France

    Active - Recruiting

  • CHU de Montpellier

    Montpellier,
    France

    Site Not Available

  • GHU Paris Psychiatrie et Neurosciences

    Paris,
    France

    Site Not Available

  • CHU de Reims

    Reims,
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.